01728nam 2200421Ia 450 991069883870332120090521103131.0(CKB)5470000002397480(OCoLC)334196478(EXLCZ)99547000000239748020090521d2004 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] recommendations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood speciments from donors of human cells, tissues and cellular and tissue-based products (HCT/Ps)Rockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2004]i, 7 pages digital, PDF fileTitle from PDF title page (viewed on May 21, 2009)."November 2004".Includes bibliographical references (page 7).Guidance for industry BloodExaminationUnited StatesCell cultureUnited StatesTestingDonation of organs, tissues, etcUnited StatesTestingCommunicable diseasesUnited StatesPreventionBloodExaminationCell cultureTesting.Donation of organs, tissues, etc.Testing.Communicable diseasesPrevention.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698838703321Guidance for industry3434577UNINA